Instrument Inactif

Communiqués Sareum Holdings Plc CINNOBER BOAT

Actions

Sareum : Half-yearly Results to Dec 2023	29/04	PU
Sareum : AGM Statement	16/12/22	PU
Sareum : Update on SAR737	12/10/22	PU
Sareum submits Clinical Trial Authorisation application to UK MHRA for development of TYK2/JAK1 inhibitor SDC-1801 and provides an Operational Update	28/07/22	GL
Sareum submits Clinical Trial Authorisation application to UK MHRA for development of TYK2/JAK1 inhibitor SDC-1801 and provides an Operational Update	28/07/22	GL
Sareum : CTA Application to MHRA and Corporate Update	28/07/22	PU
Sareum : Publication of Circular and Notice of General Meeting	04/02/22	PU
Sareum : Result of AGM	16/12/21	PU
Sareum : AGM Statement	16/12/21	PU
Sareum : Intention to Grant Notice - EU Patent for SDC-1802	15/12/21	PU
Sareum : AGM Update	07/12/21	PU
Sareum : Notice of AGM	19/11/21	PU
Appointment of Joint Corporate Broker	29/10/21	PU
Sareum : Final Results	25/10/21	PU
Sareum : Notice of Results	21/10/21	PU
Sareum : US Patent Granted for SDC-1802 TYK2/JAK1 Inhibitor	07/10/21	PU
Sareum : Reference to SRA737 Timeline at Cantor Conference	29/09/21	PU
Sareum : Patent Notice of Allowance for SDC-1802	30/07/21	PU
Sareum : Subscription to raise £1,000,000	19/07/21	PU
Sareum : Completed Covid-19 Research Project Delivers Encouraging Results	01/07/21	PU

Aucun résultat pour cette recherche